Baldwin Wealth Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-115
Closed -$9K 583
2016
Q2
$9K Hold
115
﹤0.01% 408
2016
Q1
$6K Buy
+115
New +$6.27K ﹤0.01% 437
2015
Q1
Sell
-18,735
Closed -$1.22M 263
2014
Q4
$1.22M Sell
18,735
-833
-4% -$53.6K 0.18% 120
2014
Q3
$1.18M Buy
19,568
+1,461
+8% +$95.4K 0.17% 123
2014
Q2
$1.25M Buy
18,107
+159
+0.9% +$10.3K 0.19% 110
2014
Q1
$1.17M Buy
17,948
+204
+1% +$13.3K 0.19% 110
2013
Q4
$1.1M Buy
+17,744
New +$1.03M 0.18% 118

Other funds holding STJ

Baldwin Wealth Partners's STJ Position: Q3 2016 in Review

Baldwin Wealth Partners sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 115 shares — an estimated $9K sold.

Baldwin Wealth Partners first reported a position in STJ in Q4 2013 and held it in 7 quarters. The position peaked at $1.25M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Baldwin Wealth Partners reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Baldwin Wealth Partners sold 115 St Jude Medical shares in Q3 2016, an estimated $9K.
  • Baldwin Wealth Partners first reported a position in St Jude Medical in Q4 2013 and held it in 7 quarters.
  • Baldwin Wealth Partners's St Jude Medical position peaked at $1.25M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Baldwin Wealth Partners's 13F filing for Q3 2016, filed 8 Nov 2016.